LOPERAMIDE HYDROCHLORIDE ORAL

LOPERAMIDE HYDROCHLORIDE ORAL was reported 10362 times

LOPERAMIDE HYDROCHLORIDE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 106 0.3498
1 PRESBYACUSIS 56 0.1818
2 HEART SOUNDS 15 0.1562
3 TOTAL LUNG CAPACITY INCREASED 30 0.1103
4 GENITOURINARY TRACT NEOPLASM 9 0.1084
5 STOMATITIS HAEMORRHAGIC 11 0.0902
6 FEMALE GENITAL TRACT FISTULA 112 0.0655
7 PLEURAL THICKENING 44 0.0643
8 PROLONGED EXPIRATION 15 0.0573
9 PLEURAL FIBROSIS 58 0.0569
10 LARYNGITIS VIRAL 6 0.0566
11 BLOOD MAGNESIUM INCREASED 48 0.0532
12 STOMA SITE ULCER 9 0.0508
13 METASTASES TO SPINAL CORD 9 0.0464
14 ANTICHOLINERGIC SYNDROME 73 0.0458
15 BONE HYPERTROPHY 7 0.0435
16 GASTROINTESTINAL STOMA OUTPUT INCREASED 20 0.0426
17 RADICULOPATHY 106 0.0402
18 PROCTITIS 112 0.0399
19 CHRONIC SINUSITIS 148 0.0394
20 AUTOIMMUNE NEPHRITIS 7 0.0318
21 ARRHYTHMIC STORM 9 0.0269
22 PELVIC NEOPLASM 9 0.0260
23 MACULAR DEGENERATION 272 0.0228
24 BONE CYST 21 0.0224
25 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 11 0.0219
26 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 11 0.0210
27 TUMOUR PAIN 27 0.0205
28 INCORRECT PRODUCT ADMINISTRATION DURATION 444 0.0205
29 METASTASES TO ABDOMINAL CAVITY 10 0.0203
30 HEMIANOPIA 20 0.0202
31 STICKY SKIN 8 0.0201
32 GASTROENTERITIS RADIATION 6 0.0183
33 DEAFNESS NEUROSENSORY 58 0.0176
34 LUNG DIFFUSION TEST DECREASED 7 0.0175
35 CREATININE RENAL CLEARANCE ABNORMAL 8 0.0173
36 OROPHARYNGEAL SPASM 7 0.0165
37 PEAK EXPIRATORY FLOW RATE DECREASED 7 0.0159
38 EPIGASTRIC DISCOMFORT 61 0.0156
39 ACQUIRED HAEMOPHILIA 14 0.0140
40 SALPINGECTOMY 8 0.0139
41 TORSADE DE POINTES 109 0.0139
42 NECK DEFORMITY 6 0.0135
43 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 6 0.0135
44 NIPPLE DISORDER 8 0.0129
45 OSTEOSCLEROSIS 20 0.0127
46 EXPOSURE TO TOXIC AGENT 36 0.0112
47 CHOROIDAL EFFUSION 9 0.0112
48 GASTRIC PH DECREASED 11 0.0107
49 BRUGADA SYNDROME 11 0.0106
50 VAGINAL DISCHARGE 106 0.0105
51 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 53 0.0103
52 PRODUCT INEFFECTIVE 8 0.0102
53 CAMPYLOBACTER GASTROENTERITIS 6 0.0101
54 INTENTIONAL PRODUCT USE ISSUE 868 0.0099
55 GASTROINTESTINAL STOMA COMPLICATION 15 0.0095
56 PARAESTHESIA ORAL 136 0.0094
57 VASCULAR DEVICE INFECTION 42 0.0092
58 FORCED VITAL CAPACITY DECREASED 6 0.0092
59 VANISHING BILE DUCT SYNDROME 10 0.0090
60 OOPHORECTOMY 8 0.0090
61 ORAL CANDIDIASIS 118 0.0090
62 WAIST CIRCUMFERENCE INCREASED 9 0.0087
63 FORCED EXPIRATORY VOLUME DECREASED 23 0.0081
64 GALLBLADDER POLYP 6 0.0076
65 TRAUMATIC HAEMATOMA 8 0.0074
66 NEUTROPHIL COUNT ABNORMAL 21 0.0074
67 DYSBIOSIS 6 0.0073
68 VENTRICULAR TACHYCARDIA 119 0.0072
69 RHEUMATOID FACTOR INCREASED 8 0.0072
70 CONDUCTION DISORDER 13 0.0071
71 IMMUNE-MEDIATED ENTEROCOLITIS 26 0.0071
72 EXPIRED PRODUCT ADMINISTERED 231 0.0069
73 STOMA COMPLICATION 7 0.0069
74 INCORRECT DRUG ADMINISTRATION DURATION 187 0.0066
75 LONG QT SYNDROME 15 0.0063
76 DACTYLITIS 6 0.0061
77 FREQUENT BOWEL MOVEMENTS 161 0.0060
78 DYSPLASIA 7 0.0058
79 ACCIDENTAL POISONING 8 0.0058
80 ANAL HAEMORRHAGE 16 0.0057
81 RECTAL TENESMUS 7 0.0056
82 PYELONEPHRITIS ACUTE 11 0.0056
83 PILOERECTION 6 0.0055
84 THERAPEUTIC PRODUCT EFFECT DELAYED 25 0.0055
85 VENA CAVA THROMBOSIS 9 0.0054
86 RESPIRATION ABNORMAL 37 0.0054
87 SMALL INTESTINAL PERFORATION 10 0.0053
88 CARDIOTOXICITY 47 0.0053
89 CANCER PAIN 13 0.0051
90 PROCEDURAL PAIN 141 0.0051
91 ENTEROCOLITIS 29 0.0050
92 PERIPHERAL MOTOR NEUROPATHY 7 0.0050
93 CYST 62 0.0050
94 ELECTROCARDIOGRAM QT PROLONGED 177 0.0049
95 COLITIS MICROSCOPIC 23 0.0049
96 COLITIS 184 0.0048
97 VENTRICULAR ARRHYTHMIA 17 0.0046
98 THERAPEUTIC PRODUCT EFFECT VARIABLE 18 0.0046
99 SECONDARY ADRENOCORTICAL INSUFFICIENCY 7 0.0046
100 HYPOMANIA 17 0.0046
101 ATRIOVENTRICULAR BLOCK FIRST DEGREE 20 0.0046
102 PRODUCT PACKAGING DIFFICULT TO OPEN 12 0.0046
103 DEPRESSIVE SYMPTOM 16 0.0045
104 JAUNDICE CHOLESTATIC 16 0.0045
105 APPETITE DISORDER 30 0.0045
106 MUSCULOSKELETAL CHEST PAIN 70 0.0045
107 PEPTIC ULCER 15 0.0045
108 ILEUS PARALYTIC 20 0.0045
109 FOREIGN BODY IN THROAT 14 0.0044
110 SOFT TISSUE INFECTION 8 0.0044
111 COLON CANCER METASTATIC 7 0.0043
112 OSTEOPENIA 64 0.0042
113 RHINITIS ALLERGIC 18 0.0040
114 MENTAL FATIGUE 6 0.0040
115 DRUG EFFECT DELAYED 18 0.0040
116 INTRA-ABDOMINAL FLUID COLLECTION 7 0.0039
117 FAECES DISCOLOURED 83 0.0038
118 MEGACOLON 6 0.0038
119 ABNORMAL FAECES 31 0.0038
120 DECREASED IMMUNE RESPONSIVENESS 37 0.0038
121 PNEUMONIA VIRAL 12 0.0038
122 DERMATITIS EXFOLIATIVE GENERALISED 13 0.0037
123 SMALL INTESTINAL OBSTRUCTION 46 0.0037
124 OSTEOPOROTIC FRACTURE 7 0.0037
125 BLOOD POTASSIUM INCREASED 59 0.0036
126 FAECES HARD 14 0.0036
127 PROCTALGIA 23 0.0036
128 VENTRICULAR FIBRILLATION 39 0.0035
129 FAECALOMA 19 0.0035
130 PULMONARY PAIN 10 0.0034
131 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
132 GASTROINTESTINAL PAIN 36 0.0033
133 RALES 19 0.0033
134 INTRACRANIAL PRESSURE INCREASED 18 0.0032
135 CHAPPED LIPS 14 0.0032
136 DRUG USE DISORDER 27 0.0032
137 HAEMATOCHEZIA 177 0.0032
138 RECTAL HAEMORRHAGE 135 0.0031
139 PSEUDOMEMBRANOUS COLITIS 7 0.0031
140 PORTAL VEIN THROMBOSIS 10 0.0031
141 URINE OUTPUT INCREASED 8 0.0031
142 CHOLANGITIS 19 0.0031
143 HYPOKALAEMIA 141 0.0031
144 IRON DEFICIENCY ANAEMIA 28 0.0030
145 BOWEL MOVEMENT IRREGULARITY 23 0.0030
146 ARTERIOSPASM CORONARY 12 0.0030
147 DEVICE RELATED SEPSIS 6 0.0030
148 METASTASES TO SPINE 10 0.0030
149 FRUSTRATION TOLERANCE DECREASED 24 0.0030
150 COLORECTAL CANCER METASTATIC 7 0.0030
151 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 210 0.0029
152 LARGE INTESTINAL ULCER 8 0.0029
153 BRAIN NATRIURETIC PEPTIDE INCREASED 9 0.0029
154 FAECES SOFT 21 0.0029
155 HYPOMAGNESAEMIA 40 0.0029
156 COLITIS ULCERATIVE 128 0.0029
157 LUNG ABSCESS 6 0.0029
158 NASAL POLYPS 14 0.0028
159 HYPOPHOSPHATAEMIA 21 0.0028
160 MUCOUS STOOLS 14 0.0028
161 PYODERMA GANGRENOSUM 10 0.0028
162 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 18 0.0028
163 SKIN LESION 76 0.0028
164 SARCOIDOSIS 13 0.0027
165 TUMOUR MARKER INCREASED 13 0.0027
166 THORACIC VERTEBRAL FRACTURE 8 0.0027
167 HYPOALBUMINAEMIA 21 0.0027
168 TOXIC EPIDERMAL NECROLYSIS 41 0.0027
169 ENTERITIS 17 0.0027
170 KERATITIS 8 0.0026
171 GASTROINTESTINAL SOUNDS ABNORMAL 13 0.0026
172 CONSTIPATION 569 0.0026
173 MALNUTRITION 29 0.0026
174 LUNG NEOPLASM 11 0.0026
175 DRUG EFFECT LESS THAN EXPECTED 38 0.0026
176 BLOOD PHOSPHORUS INCREASED 7 0.0026
177 PNEUMONIA ASPIRATION 64 0.0026
178 BLOOD CREATININE DECREASED 8 0.0026
179 OBSTRUCTIVE AIRWAYS DISORDER 28 0.0025
180 OESOPHAGEAL CANDIDIASIS 10 0.0025
181 ILEUS 31 0.0025
182 ONYCHOCLASIS 17 0.0025
183 PNEUMATOSIS INTESTINALIS 7 0.0025
184 LARGE INTESTINE PERFORATION 17 0.0024
185 RESPIRATORY DEPRESSION 30 0.0024
186 ANAL FISSURE 13 0.0024
187 DRUG ABUSE 201 0.0024
188 BLOOD CREATININE INCREASED 157 0.0024
189 NEUTROPHIL COUNT DECREASED 98 0.0024
190 DRUG LEVEL ABOVE THERAPEUTIC 11 0.0024
191 NEPHRITIS 8 0.0024
192 HYPERPARATHYROIDISM SECONDARY 6 0.0024
193 METASTASES TO PERITONEUM 6 0.0024
194 TONGUE DISCOMFORT 10 0.0024
195 FEBRILE BONE MARROW APLASIA 10 0.0024
196 ABDOMINAL INFECTION 6 0.0023
197 ANAL INCONTINENCE 21 0.0023
198 THYROIDITIS 7 0.0023
199 INTENTIONAL PRODUCT MISUSE 204 0.0023
200 LUNG ADENOCARCINOMA 7 0.0023
201 ELECTROLYTE IMBALANCE 27 0.0023
202 LEFT VENTRICULAR FAILURE 8 0.0023
203 APHTHOUS ULCER 18 0.0023
204 BLOOD MAGNESIUM DECREASED 20 0.0023
205 INFUSION RELATED REACTION 153 0.0023
206 EXOSTOSIS 21 0.0023
207 DYSCHEZIA 7 0.0023
208 LUNG OPACITY 6 0.0023
209 PARONYCHIA 10 0.0023
210 CATHETERISATION CARDIAC 10 0.0023
211 DEFORMITY 21 0.0022
212 BRONCHIECTASIS 15 0.0022
213 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
214 BRADYPNOEA 6 0.0022
215 DYSPEPSIA 218 0.0022
216 URINE ABNORMALITY 10 0.0022
217 PNEUMONITIS 59 0.0022
218 PANCREATITIS ACUTE 47 0.0021
219 CLAVICLE FRACTURE 8 0.0021
220 ANAL FISTULA 11 0.0021
221 C-REACTIVE PROTEIN INCREASED 75 0.0021
222 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14 0.0021
223 DIVERTICULUM INTESTINAL 9 0.0021
224 MELANOCYTIC NAEVUS 9 0.0021
225 FLANK PAIN 19 0.0020
226 DIARRHOEA 1307 0.0020
227 PULMONARY THROMBOSIS 22 0.0020
228 TENDERNESS 21 0.0020
229 UNDERDOSE 146 0.0020
230 BLOOD PRESSURE SYSTOLIC INCREASED 39 0.0020
231 HYPERCAPNIA 6 0.0020
232 DUODENAL ULCER 14 0.0020
233 DERMATITIS ACNEIFORM 12 0.0020
234 HAEMORRHAGIC DIATHESIS 7 0.0020
235 FISTULA 22 0.0020
236 DUODENITIS 6 0.0020
237 PNEUMOTHORAX 31 0.0020
238 RENAL FUNCTION TEST ABNORMAL 9 0.0019
239 METASTASES TO LYMPH NODES 13 0.0019
240 THYROID FUNCTION TEST ABNORMAL 8 0.0019
241 GASTROINTESTINAL PERFORATION 8 0.0019
242 OSTEOARTHRITIS 81 0.0019
243 SENSITIVITY TO WEATHER CHANGE 10 0.0019
244 HYPOVOLAEMIA 11 0.0019
245 LYMPHOEDEMA 13 0.0019
246 ABSCESS LIMB 8 0.0019
247 HUNGER 26 0.0019
248 BLOOD IRON DECREASED 22 0.0019
249 GASTROENTERITIS 27 0.0018
250 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
251 CARDIAC MURMUR 16 0.0018
252 ANAEMIA 350 0.0018
253 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
254 STOMATITIS 111 0.0018
255 SCHIZOPHRENIA 22 0.0018
256 ORAL DISCOMFORT 25 0.0018
257 RHINOVIRUS INFECTION 7 0.0018
258 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
259 ELECTROCARDIOGRAM ABNORMAL 14 0.0018
260 DEHYDRATION 237 0.0018
261 SUSPECTED OFF LABEL USE 8 0.0018
262 FLATULENCE 100 0.0018
263 BRONCHOPNEUMONIA 6 0.0018
264 HYPOCALCAEMIA 33 0.0017
265 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
266 BLOOD BILIRUBIN INCREASED 47 0.0017
267 SKIN FISSURES 34 0.0017
268 ABDOMINAL PAIN 402 0.0017
269 PAROSMIA 13 0.0017
270 WHEEZING 102 0.0017
271 C-REACTIVE PROTEIN ABNORMAL 11 0.0017
272 DEFAECATION URGENCY 12 0.0017
273 RIGHT VENTRICULAR FAILURE 12 0.0017
274 DIARRHOEA HAEMORRHAGIC 16 0.0017
275 ERYTHEMA NODOSUM 6 0.0017
276 SELF-MEDICATION 7 0.0017
277 HYPERURICAEMIA 7 0.0017
278 RENAL PAIN 18 0.0017
279 ANORECTAL DISCOMFORT 9 0.0017
280 NEUTROPENIC SEPSIS 12 0.0017
281 PRODUCT RESIDUE PRESENT 9 0.0017
282 HEPATIC FUNCTION ABNORMAL 62 0.0017
283 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 17 0.0017
284 SINUS BRADYCARDIA 16 0.0017
285 AFFECTIVE DISORDER 13 0.0017
286 MONOCYTE COUNT INCREASED 6 0.0017
287 DIZZINESS POSTURAL 16 0.0016
288 OESOPHAGITIS 18 0.0016
289 FEBRILE NEUTROPENIA 109 0.0016
290 INFLAMMATORY BOWEL DISEASE 16 0.0016
291 PNEUMONIA BACTERIAL 15 0.0016
292 MIOSIS 13 0.0016
293 OLIGURIA 10 0.0016
294 ORAL PAIN 36 0.0016
295 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 289 0.0016
296 INTESTINAL OBSTRUCTION 60 0.0016
297 HAEMORRHOIDS 31 0.0016
298 CHOLECYSTITIS ACUTE 9 0.0016
299 ABDOMINAL ABSCESS 7 0.0016
300 DYSPHORIA 8 0.0016
301 DECREASED APPETITE 364 0.0016
302 PRESYNCOPE 38 0.0016
303 CARDIAC ARREST 129 0.0016
304 PERIPHERAL VASCULAR DISORDER 8 0.0016
305 CONTRAINDICATED PRODUCT ADMINISTERED 47 0.0016
306 ASPIRATION 17 0.0016
307 PRODUCT TASTE ABNORMAL 21 0.0015
308 TRISMUS 8 0.0015
309 SKIN WARM 9 0.0015
310 DRY EYE 77 0.0015
311 PERIORBITAL OEDEMA 8 0.0015
312 HEPATITIS ACUTE 10 0.0015
313 ABDOMINAL HERNIA 7 0.0015
314 COMA 73 0.0015
315 ACUTE GRAFT VERSUS HOST DISEASE 7 0.0015
316 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
317 TASTE DISORDER 31 0.0015
318 HYPERTHYROIDISM 22 0.0015
319 INTESTINAL PERFORATION 17 0.0015
320 NEPHROGENIC ANAEMIA 7 0.0015
321 ATRIAL FLUTTER 12 0.0015
322 OBSTRUCTION 6 0.0015
323 RENAL IMPAIRMENT 126 0.0015
324 BRAIN INJURY 15 0.0015
325 YELLOW SKIN 7 0.0015
326 GASTROINTESTINAL MOTILITY DISORDER 8 0.0015
327 SENSITIVE SKIN 11 0.0015
328 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
329 BLOOD ALKALINE PHOSPHATASE INCREASED 37 0.0015
330 BREAST CANCER METASTATIC 16 0.0015
331 MYDRIASIS 19 0.0015
332 METASTASES TO LIVER 26 0.0015
333 WEIGHT DECREASED 412 0.0015
334 LOWER RESPIRATORY TRACT INFECTION 67 0.0015
335 FEELING COLD 41 0.0015
336 DECUBITUS ULCER 12 0.0015
337 NON-SMALL CELL LUNG CANCER 7 0.0015
338 HYPONATRAEMIA 82 0.0015
339 INTESTINAL ISCHAEMIA 8 0.0015
340 ENTEROCOCCAL INFECTION 7 0.0014
341 HAEMODYNAMIC INSTABILITY 11 0.0014
342 ACIDOSIS 11 0.0014
343 ABDOMINAL DISTENSION 150 0.0014
344 VITAMIN D DEFICIENCY 14 0.0014
345 INFUSION SITE SWELLING 9 0.0014
346 ASCITES 42 0.0014
347 HYPERVOLAEMIA 7 0.0014
348 PULMONARY TOXICITY 10 0.0014
349 MUCOSAL INFLAMMATION 37 0.0014
350 URINARY RETENTION 47 0.0014
351 HYPERAMMONAEMIA 7 0.0014
352 CARDIOGENIC SHOCK 20 0.0014
353 ERYTHEMA MULTIFORME 13 0.0014
354 MUSCLE STRAIN 12 0.0014
355 METASTASES TO LUNG 16 0.0014
356 ANGINA UNSTABLE 9 0.0014
357 DYSLIPIDAEMIA 7 0.0014
358 DRUG LEVEL DECREASED 14 0.0014
359 CHROMATURIA 31 0.0014
360 POISONING DELIBERATE 13 0.0014
361 PRODUCT PACKAGING ISSUE 13 0.0014
362 SKIN ULCER 35 0.0014
363 GASTROINTESTINAL DISORDER 121 0.0013
364 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
365 BACTERAEMIA 16 0.0013
366 WHITE BLOOD CELL COUNT DECREASED 146 0.0013
367 HYPOTHYROIDISM 43 0.0013
368 ATELECTASIS 13 0.0013
369 MALABSORPTION 7 0.0013
370 HICCUPS 11 0.0013
371 OVERDOSE 289 0.0013
372 POLYNEUROPATHY 16 0.0013
373 IRON DEFICIENCY 6 0.0013
374 COLITIS ISCHAEMIC 9 0.0013
375 BLOOD CALCIUM DECREASED 15 0.0013
376 PYREXIA 461 0.0013
377 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 31 0.0013
378 BLOOD LACTIC ACID INCREASED 7 0.0013
379 NEUTROPENIA 179 0.0013
380 HAEMOGLOBIN INCREASED 6 0.0013
381 ACCIDENTAL OVERDOSE 48 0.0013
382 IMMUNE THROMBOCYTOPENIA 6 0.0013
383 ANAL ABSCESS 7 0.0013
384 TOXIC SKIN ERUPTION 13 0.0013
385 ISCHAEMIC STROKE 23 0.0013
386 BLOOD TEST ABNORMAL 18 0.0013
387 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 91 0.0013
388 DRUG LEVEL BELOW THERAPEUTIC 7 0.0013
389 DRUG LEVEL INCREASED 21 0.0013
390 GASTRIC ULCER 24 0.0013
391 LIMB DISCOMFORT 39 0.0013
392 URINE OUTPUT DECREASED 11 0.0013
393 BLOOD UREA INCREASED 21 0.0013
394 SPINAL OSTEOARTHRITIS 11 0.0013
395 TUMOUR LYSIS SYNDROME 11 0.0012
396 SLEEP DISORDER 88 0.0012
397 CONJUNCTIVITIS 23 0.0012
398 SKIN TOXICITY 7 0.0012
399 HIATUS HERNIA 16 0.0012
400 DEVICE RELATED INFECTION 19 0.0012
401 PLEURAL EFFUSION 75 0.0012
402 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 36 0.0012
403 HAEMORRHOIDAL HAEMORRHAGE 6 0.0012
404 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
405 CHOLELITHIASIS 40 0.0012
406 OROPHARYNGEAL DISCOMFORT 11 0.0012
407 INTENTIONAL OVERDOSE 78 0.0012
408 HEPATOTOXICITY 27 0.0012
409 ORGANISING PNEUMONIA 6 0.0012
410 ABDOMINAL TENDERNESS 6 0.0012
411 LIVER FUNCTION TEST ABNORMAL 35 0.0012
412 FLUID INTAKE REDUCED 6 0.0012
413 SPLENOMEGALY 14 0.0012
414 PRODUCTIVE COUGH 57 0.0012
415 LEUKOPENIA 59 0.0012
416 EPILEPSY 36 0.0012
417 INTERSTITIAL LUNG DISEASE 57 0.0012
418 PLATELET COUNT DECREASED 125 0.0012
419 MALIGNANT NEOPLASM PROGRESSION 120 0.0012
420 PROTHROMBIN TIME PROLONGED 7 0.0012
421 CACHEXIA 6 0.0012
422 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
423 HAIR GROWTH ABNORMAL 8 0.0012
424 PYELONEPHRITIS 10 0.0012
425 WEIGHT FLUCTUATION 12 0.0011
426 ADVERSE REACTION 15 0.0011
427 NYSTAGMUS 6 0.0011
428 SCIATICA 18 0.0011
429 OFF LABEL USE 987 0.0011
430 COMPRESSION FRACTURE 6 0.0011
431 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 19 0.0011
432 RIB FRACTURE 23 0.0011
433 HAEMATOCRIT DECREASED 22 0.0011
434 ALANINE AMINOTRANSFERASE INCREASED 68 0.0011
435 SHOCK HAEMORRHAGIC 9 0.0011
436 PULMONARY ARTERIAL HYPERTENSION 16 0.0011
437 BLOOD POTASSIUM DECREASED 33 0.0011
438 ACUTE CORONARY SYNDROME 9 0.0011
439 TOXICITY TO VARIOUS AGENTS 183 0.0011
440 UROSEPSIS 10 0.0011
441 ANGINA PECTORIS 31 0.0011
442 ASPARTATE AMINOTRANSFERASE INCREASED 57 0.0011
443 ADRENAL INSUFFICIENCY 13 0.0011
444 POLYP 7 0.0011
445 GASTROOESOPHAGEAL REFLUX DISEASE 86 0.0011
446 ASPERGILLUS INFECTION 7 0.0011
447 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
448 PERIORBITAL SWELLING 6 0.0011
449 PEMPHIGOID 8 0.0011
450 DRUG INTERACTION 168 0.0011
451 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
452 TROPONIN INCREASED 8 0.0011
453 CARDIAC FAILURE ACUTE 7 0.0010
454 THROMBOCYTOPENIA 117 0.0010
455 HERPES VIRUS INFECTION 6 0.0010
456 POST PROCEDURAL COMPLICATION 20 0.0010
457 PANCREATITIS 55 0.0010
458 ABDOMINAL PAIN UPPER 214 0.0010
459 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
460 PERICARDIAL EFFUSION 24 0.0010
461 WRONG PRODUCT ADMINISTERED 7 0.0010
462 FEEDING DISORDER 21 0.0010
463 METABOLIC ACIDOSIS 33 0.0010
464 LUNG INFECTION 16 0.0010
465 ACUTE KIDNEY INJURY 157 0.0010
466 HAEMATEMESIS 26 0.0010
467 LUNG INFILTRATION 9 0.0010
468 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
469 LYMPHOCYTE COUNT DECREASED 18 0.0010
470 ENCEPHALOPATHY 25 0.0010
471 BODY TEMPERATURE DECREASED 10 0.0010
472 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
473 DRUG INTOLERANCE 98 0.0010
474 SEPTIC SHOCK 44 0.0010
475 BLOOD SODIUM DECREASED 19 0.0010
476 THIRST 18 0.0010
477 CHOLECYSTITIS 12 0.0010
478 GASTROINTESTINAL INFECTION 9 0.0010
479 DEPRESSED MOOD 53 0.0010
480 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
481 PAPULE 7 0.0010
482 DRUG INEFFECTIVE 1308 0.0010
483 SYNCOPE 99 0.0010
484 ABDOMINAL PAIN LOWER 25 0.0010
485 SEPSIS 110 0.0010
486 DYSPNOEA EXERTIONAL 37 0.0010
487 INCORRECT DOSE ADMINISTERED 224 0.0010
488 NAUSEA 776 0.0010
489 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
490 PHOTOSENSITIVITY REACTION 16 0.0010
491 DERMATITIS BULLOUS 7 0.0010
492 RHINORRHOEA 62 0.0010
493 BRAIN FOG 15 0.0010
494 DERMATITIS ALLERGIC 12 0.0010
495 INFECTION 138 0.0010
496 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 52 0.0009
497 PROTEINURIA 18 0.0009
498 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
499 JOINT DISLOCATION 10 0.0009
500 INCREASED APPETITE 18 0.0009
501 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
502 OROPHARYNGEAL PAIN 87 0.0009
503 LETHARGY 54 0.0009
504 RETCHING 20 0.0009
505 IRRITABLE BOWEL SYNDROME 20 0.0009
506 METASTASES TO CENTRAL NERVOUS SYSTEM 12 0.0009
507 PRESCRIBED OVERDOSE 18 0.0009
508 BRADYCARDIA 49 0.0009
509 DYSURIA 34 0.0009
510 PNEUMONIA 298 0.0009
511 PLATELET COUNT INCREASED 12 0.0009
512 PERITONITIS 19 0.0009
513 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
514 NAIL DISORDER 8 0.0009
515 DYSGRAPHIA 6 0.0009
516 RENAL FAILURE CHRONIC 7 0.0009
517 OXYGEN SATURATION DECREASED 51 0.0009
518 PURPURA 8 0.0009
519 LIVER DISORDER 40 0.0009
520 MALAISE 395 0.0009
521 HYPOPHAGIA 23 0.0009
522 RASH MACULO-PAPULAR 20 0.0009
523 CYTOPENIA 11 0.0009
524 POST-TRAUMATIC STRESS DISORDER 6 0.0009
525 NEUROPATHY PERIPHERAL 85 0.0009
526 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
527 NEPHROPATHY TOXIC 10 0.0009
528 MOBILITY DECREASED 64 0.0009
529 POSTOPERATIVE WOUND INFECTION 6 0.0009
530 ABDOMINAL DISCOMFORT 149 0.0009
531 NEPHROTIC SYNDROME 6 0.0009
532 EAR PAIN 17 0.0009
533 VOMITING 411 0.0009
534 BRAIN OEDEMA 11 0.0009
535 THERAPEUTIC PRODUCT EFFECT DECREASED 39 0.0009
536 RETINAL DETACHMENT 8 0.0009
537 TACHYCARDIA 77 0.0009
538 LARGE INTESTINE POLYP 6 0.0009
539 HYPERTRANSAMINASAEMIA 6 0.0009
540 HEPATIC FAILURE 26 0.0009
541 OEDEMA PERIPHERAL 105 0.0009
542 BACTERIAL INFECTION 16 0.0009
543 INJECTION SITE DISCOMFORT 9 0.0009
544 FULL BLOOD COUNT ABNORMAL 9 0.0009
545 PHOTOPHOBIA 16 0.0008
546 OEDEMA 46 0.0008
547 CYSTITIS 27 0.0008
548 CYTOKINE RELEASE SYNDROME 17 0.0008
549 PAIN IN JAW 24 0.0008
550 ARRHYTHMIA 40 0.0008
551 DIVERTICULUM 6 0.0008
552 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 44 0.0008
553 INTENTIONAL SELF-INJURY 17 0.0008
554 PANCYTOPENIA 47 0.0008
555 TENDONITIS 13 0.0008
556 MYOCLONUS 10 0.0008
557 NIGHT SWEATS 27 0.0008
558 POOR QUALITY SLEEP 18 0.0008
559 FATIGUE 650 0.0008
560 BLOOD PRESSURE FLUCTUATION 20 0.0008
561 SENSATION OF FOREIGN BODY 7 0.0008
562 ERYTHEMA 170 0.0008
563 HYPERKALAEMIA 29 0.0008
564 PRODUCT USE COMPLAINT 13 0.0008
565 HYPERGLYCAEMIA 30 0.0008
566 DISCOMFORT 50 0.0008
567 ORAL DISORDER 6 0.0008
568 HAEMOGLOBIN DECREASED 84 0.0008
569 STEVENS-JOHNSON SYNDROME 18 0.0008
570 URINARY TRACT INFECTION 138 0.0008
571 TREATMENT FAILURE 67 0.0008
572 GENERALISED OEDEMA 10 0.0008
573 MOUTH ULCERATION 17 0.0008
574 HYPOXIA 28 0.0008
575 FULL BLOOD COUNT DECREASED 16 0.0008
576 PERIPHERAL SWELLING 122 0.0008
577 SEIZURE 91 0.0008
578 BONE PAIN 46 0.0008
579 LIPASE INCREASED 6 0.0008
580 SHOCK 18 0.0008
581 INFLUENZA 87 0.0008
582 SOMNOLENCE 157 0.0008
583 RENAL FAILURE ACUTE 33 0.0008
584 MYELOSUPPRESSION 28 0.0008
585 SEASONAL ALLERGY 11 0.0008
586 ANOREXIA 10 0.0008
587 CONFUSIONAL STATE 125 0.0008
588 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
589 LIP DRY 7 0.0008
590 CHILLS 90 0.0008
591 BLOOD PRESSURE DECREASED 51 0.0008
592 HERPES ZOSTER 44 0.0008
593 NERVOUSNESS 40 0.0008
594 TRANSFUSION 8 0.0008
595 HAEMATURIA 26 0.0008
596 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
597 SNEEZING 17 0.0008
598 INCONTINENCE 8 0.0008
599 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
600 BLOOD ALBUMIN DECREASED 6 0.0008
601 HYPERLIPIDAEMIA 9 0.0008
602 ABSCESS 12 0.0008
603 HEPATIC ENCEPHALOPATHY 7 0.0007
604 ASTHENIA 282 0.0007
605 APPENDICITIS 7 0.0007
606 QUALITY OF LIFE DECREASED 10 0.0007
607 PRODUCT ADMINISTRATION ERROR 15 0.0007
608 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21 0.0007
609 LACTIC ACIDOSIS 24 0.0007
610 BONE MARROW FAILURE 15 0.0007
611 POST PROCEDURAL INFECTION 6 0.0007
612 UNRESPONSIVE TO STIMULI 19 0.0007
613 THROAT IRRITATION 33 0.0007
614 MENTAL DISORDER 32 0.0007
615 BODY TEMPERATURE INCREASED 15 0.0007
616 DEPRESSED LEVEL OF CONSCIOUSNESS 29 0.0007
617 MUSCULOSKELETAL STIFFNESS 64 0.0007
618 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
619 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 35 0.0007
620 MELAENA 16 0.0007
621 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
622 GASTRITIS 19 0.0007
623 DIVERTICULITIS 20 0.0007
624 AGEUSIA 18 0.0007
625 SYNOVITIS 13 0.0007
626 OSTEOMYELITIS 13 0.0007
627 COORDINATION ABNORMAL 10 0.0007
628 DISEASE PROGRESSION 84 0.0007
629 STATUS EPILEPTICUS 8 0.0007
630 LYMPHOPENIA 10 0.0007
631 PAIN OF SKIN 19 0.0007
632 DRUG EFFECT DECREASED 38 0.0007
633 FACIAL PARALYSIS 6 0.0007
634 COUGH 197 0.0007
635 ARTHROPATHY 39 0.0007
636 INFUSION SITE PAIN 9 0.0007
637 CARDIAC FAILURE 56 0.0007
638 IMPAIRED QUALITY OF LIFE 10 0.0007
639 MULTI-ORGAN FAILURE 12 0.0007
640 HYPOTENSION 139 0.0007
641 DELIRIUM 24 0.0007
642 RESPIRATORY TRACT INFECTION 18 0.0007
643 WITHDRAWAL SYNDROME 29 0.0007
644 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
645 CATARACT 41 0.0007
646 BLOOD CHOLESTEROL INCREASED 32 0.0007
647 APATHY 10 0.0007
648 ANHEDONIA 18 0.0007
649 HYPERTENSION 145 0.0007
650 DYSPHONIA 40 0.0007
651 EAR DISCOMFORT 7 0.0007
652 POOR VENOUS ACCESS 7 0.0007
653 GENERAL PHYSICAL HEALTH DETERIORATION 78 0.0007
654 VENTRICULAR EXTRASYSTOLES 7 0.0007
655 HERNIA 13 0.0007
656 GALLBLADDER DISORDER 12 0.0007
657 POLLAKIURIA 28 0.0007
658 COLON CANCER 10 0.0007
659 MUSCLE SPASMS 123 0.0007
660 DRUG-INDUCED LIVER INJURY 21 0.0007
661 SINUS CONGESTION 9 0.0007
662 RENAL DISORDER 31 0.0007
663 HEART RATE IRREGULAR 15 0.0007
664 TOOTHACHE 12 0.0007
665 SUDDEN DEATH 7 0.0007
666 ECONOMIC PROBLEM 10 0.0007
667 DISORIENTATION 26 0.0007
668 DYSPHAGIA 62 0.0007
669 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
670 CANDIDA INFECTION 11 0.0007
671 CARDIOMEGALY 8 0.0006
672 GRAND MAL CONVULSION 6 0.0006
673 DECREASED ACTIVITY 7 0.0006
674 NASAL CONGESTION 38 0.0006
675 AGRANULOCYTOSIS 12 0.0006
676 HEPATIC ENZYME INCREASED 44 0.0006
677 THINKING ABNORMAL 12 0.0006
678 EJECTION FRACTION DECREASED 10 0.0006
679 HAIR COLOUR CHANGES 8 0.0006
680 PULMONARY EMBOLISM 61 0.0006
681 THERAPY PARTIAL RESPONDER 10 0.0006
682 DEVICE OCCLUSION 9 0.0006
683 DYSPNOEA 362 0.0006
684 COVID-19 112 0.0006
685 HEART RATE INCREASED 63 0.0006
686 HYPOAESTHESIA 95 0.0006
687 ANAPHYLACTIC REACTION 35 0.0006
688 MUSCLE ATROPHY 8 0.0006
689 RED BLOOD CELL COUNT DECREASED 18 0.0006
690 NERVE INJURY 7 0.0006
691 RASH MACULAR 22 0.0006
692 EPISTAXIS 47 0.0006
693 HEPATITIS 16 0.0006
694 PULMONARY OEDEMA 28 0.0006
695 HEADACHE 392 0.0006
696 CONTUSION 60 0.0006
697 JOINT SWELLING 75 0.0006
698 INFLAMMATION 32 0.0006
699 PAIN 380 0.0006
700 HOSPITALISATION 95 0.0006
701 FIBROMYALGIA 15 0.0006
702 PLASMA CELL MYELOMA 24 0.0006
703 GOUT 11 0.0006
704 MENTAL STATUS CHANGES 17 0.0006
705 SPEECH DISORDER 32 0.0006
706 HOT FLUSH 46 0.0006
707 JOINT INJURY 13 0.0006
708 DRY SKIN 81 0.0006
709 BLISTER 34 0.0006
710 IMMUNODEFICIENCY 9 0.0006
711 CYTOMEGALOVIRUS INFECTION 10 0.0006
712 PRESCRIBED UNDERDOSE 12 0.0006
713 PAIN IN EXTREMITY 177 0.0006
714 RHABDOMYOLYSIS 25 0.0006
715 HYPOAESTHESIA ORAL 9 0.0006
716 JOINT RANGE OF MOTION DECREASED 8 0.0006
717 JAUNDICE 16 0.0006
718 VERTIGO 36 0.0006
719 HEPATIC STEATOSIS 11 0.0006
720 HEMIPARESIS 10 0.0006
721 BALANCE DISORDER 51 0.0006
722 ATAXIA 7 0.0006
723 MOTOR DYSFUNCTION 6 0.0006
724 CIRCULATORY COLLAPSE 10 0.0006
725 EUPHORIC MOOD 6 0.0006
726 ARTHRALGIA 242 0.0006
727 BACK PAIN 135 0.0006
728 MUSCULOSKELETAL DISCOMFORT 10 0.0006
729 IMPAIRED HEALING 19 0.0006
730 NOCTURIA 7 0.0006
731 PULMONARY HYPERTENSION 12 0.0006
732 NEOPLASM PROGRESSION 20 0.0006
733 PETECHIAE 6 0.0006
734 FOLLICULITIS 6 0.0006
735 GLAUCOMA 11 0.0006
736 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
737 HEART RATE DECREASED 20 0.0006
738 DRUG ERUPTION 10 0.0006
739 CHOKING 11 0.0006
740 EATING DISORDER 12 0.0006
741 INSOMNIA 150 0.0006
742 ARTHRITIS 44 0.0006
743 HYPERSOMNIA 16 0.0006
744 POISONING 7 0.0006
745 CHEST PAIN 103 0.0006
746 CELLULITIS 28 0.0006
747 LOSS OF CONSCIOUSNESS 71 0.0006
748 GAIT DISTURBANCE 106 0.0006
749 NASOPHARYNGITIS 102 0.0006
750 DYSGEUSIA 41 0.0006
751 PRODUCT PRESCRIBING ISSUE 12 0.0006
752 RESTLESS LEGS SYNDROME 10 0.0005
753 HYPERSENSITIVITY 102 0.0005
754 METASTASES TO BONE 9 0.0005
755 CHEST DISCOMFORT 56 0.0005
756 ATRIAL FIBRILLATION 53 0.0005
757 RESPIRATORY DISTRESS 15 0.0005
758 PSYCHOTIC DISORDER 16 0.0005
759 URINARY INCONTINENCE 16 0.0005
760 TRANSAMINASES INCREASED 12 0.0005
761 TOOTH DISORDER 12 0.0005
762 DEEP VEIN THROMBOSIS 35 0.0005
763 GLOSSODYNIA 12 0.0005
764 RASH PRURITIC 29 0.0005
765 HEPATIC CIRRHOSIS 10 0.0005
766 FALL 177 0.0005
767 PULMONARY CONGESTION 7 0.0005
768 LUNG DISORDER 26 0.0005
769 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
770 CONDITION AGGRAVATED 161 0.0005
771 CORONARY ARTERY DISEASE 16 0.0005
772 SUICIDE ATTEMPT 32 0.0005
773 RENAL FAILURE 70 0.0005
774 DERMATITIS CONTACT 6 0.0005
775 EAR INFECTION 14 0.0005
776 INSURANCE ISSUE 8 0.0005
777 NEOPLASM 6 0.0005
778 ALOPECIA 102 0.0005
779 OSTEONECROSIS 17 0.0005
780 ORTHOSTATIC HYPOTENSION 9 0.0005
781 POST PROCEDURAL HAEMORRHAGE 6 0.0005
782 TACHYPNOEA 7 0.0005
783 PALLOR 14 0.0005
784 DIZZINESS 256 0.0005
785 LIVER FUNCTION TEST INCREASED 11 0.0005
786 SWOLLEN TONGUE 16 0.0005
787 OSTEOPOROSIS 21 0.0005
788 CORONARY ARTERY OCCLUSION 7 0.0005
789 KIDNEY INFECTION 10 0.0005
790 ACUTE MYOCARDIAL INFARCTION 15 0.0005
791 COVID-19 PNEUMONIA 6 0.0005
792 DRY MOUTH 41 0.0005
793 ASTHMA 57 0.0005
794 PRODUCT PRESCRIBING ERROR 12 0.0005
795 ULCER 8 0.0005
796 NEPHROLITHIASIS 23 0.0005
797 MYALGIA 85 0.0005
798 CARPAL TUNNEL SYNDROME 7 0.0005
799 IRRITABILITY 30 0.0005
800 BLOOD PRESSURE INCREASED 76 0.0005
801 RHEUMATOID ARTHRITIS 56 0.0005
802 RESTLESSNESS 18 0.0005
803 GASTROINTESTINAL HAEMORRHAGE 41 0.0005
804 LIVER INJURY 12 0.0005
805 INJECTION SITE EXTRAVASATION 6 0.0005
806 HYPERCALCAEMIA 6 0.0005
807 MUSCULAR WEAKNESS 55 0.0005
808 SWELLING 45 0.0005
809 DYSSTASIA 14 0.0005
810 WEIGHT INCREASED 107 0.0005
811 PARAESTHESIA 75 0.0005
812 FACE OEDEMA 8 0.0005
813 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
814 SKIN EXFOLIATION 40 0.0005
815 CARDIOMYOPATHY 7 0.0005
816 BRONCHITIS 35 0.0005
817 RESPIRATORY ARREST 13 0.0005
818 PULMONARY MASS 7 0.0005
819 MOVEMENT DISORDER 15 0.0005
820 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
821 SKIN CANCER 10 0.0005
822 HALLUCINATION 35 0.0005
823 PRODUCT USE IN UNAPPROVED INDICATION 115 0.0005
824 HAEMATOMA 12 0.0005
825 DIPLOPIA 12 0.0005
826 VISUAL IMPAIRMENT 57 0.0005
827 NEUROTOXICITY 8 0.0005
828 EOSINOPHILIA 8 0.0005
829 RASH 199 0.0005
830 PRODUCT DOSE OMISSION ISSUE 134 0.0005
831 ROAD TRAFFIC ACCIDENT 19 0.0005
832 COLD SWEAT 8 0.0005
833 MENTAL IMPAIRMENT 11 0.0005
834 PALPITATIONS 53 0.0005
835 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
836 EYE HAEMORRHAGE 6 0.0004
837 MALIGNANT MELANOMA 6 0.0004
838 NECK PAIN 25 0.0004
839 LIMB INJURY 12 0.0004
840 PANIC ATTACK 16 0.0004
841 TREATMENT NONCOMPLIANCE 24 0.0004
842 SENSORY DISTURBANCE 7 0.0004
843 URTICARIA 73 0.0004
844 TREMOR 72 0.0004
845 BLOOD GLUCOSE ABNORMAL 8 0.0004
846 CARDIO-RESPIRATORY ARREST 18 0.0004
847 DERMATITIS 9 0.0004
848 MEMORY IMPAIRMENT 59 0.0004
849 DYSARTHRIA 16 0.0004
850 THERAPY NON-RESPONDER 19 0.0004
851 AGITATION 31 0.0004
852 BLOOD URINE PRESENT 8 0.0004
853 LIP SWELLING 14 0.0004
854 SKIN DISORDER 14 0.0004
855 SLEEP APNOEA SYNDROME 8 0.0004
856 RASH ERYTHEMATOUS 20 0.0004
857 ACUTE RESPIRATORY FAILURE 8 0.0004
858 DRUG EFFECT INCOMPLETE 15 0.0004
859 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 83 0.0004
860 ANXIETY 116 0.0004
861 RESPIRATORY FAILURE 29 0.0004
862 APHASIA 12 0.0004
863 LACRIMATION INCREASED 12 0.0004
864 PRODUCT PHYSICAL ISSUE 8 0.0004
865 SKIN DISCOLOURATION 18 0.0004
866 CEREBRAL HAEMORRHAGE 14 0.0004
867 LUNG NEOPLASM MALIGNANT 16 0.0004
868 EMOTIONAL DISORDER 12 0.0004
869 ILLNESS 40 0.0004
870 VISION BLURRED 53 0.0004
871 TOOTH LOSS 8 0.0004
872 BASAL CELL CARCINOMA 6 0.0004
873 ANGER 13 0.0004
874 END STAGE RENAL DISEASE 7 0.0004
875 DEAFNESS 10 0.0004
876 CHRONIC KIDNEY DISEASE 29 0.0004
877 CYANOSIS 6 0.0004
878 HEAD INJURY 12 0.0004
879 FEELING HOT 23 0.0004
880 FLUID RETENTION 19 0.0004
881 HYPOGLYCAEMIA 18 0.0004
882 INJURY 26 0.0004
883 CEREBRAL INFARCTION 9 0.0004
884 ADVERSE DRUG REACTION 33 0.0004
885 LYMPHADENOPATHY 13 0.0004
886 FEELING ABNORMAL 88 0.0004
887 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
888 HYPERHIDROSIS 47 0.0004
889 CHOLESTASIS 7 0.0004
890 INFLUENZA LIKE ILLNESS 30 0.0004
891 ERUCTATION 7 0.0004
892 WOUND 10 0.0004
893 CARDIOVASCULAR DISORDER 9 0.0004
894 SWELLING FACE 23 0.0004
895 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
896 SPINAL FRACTURE 7 0.0003
897 ANAPHYLACTIC SHOCK 9 0.0003
898 CEREBROVASCULAR ACCIDENT 59 0.0003
899 PRODUCT USE ISSUE 65 0.0003
900 ECZEMA 18 0.0003
901 MYOCARDIAL INFARCTION 60 0.0003
902 LABORATORY TEST ABNORMAL 10 0.0003
903 GASTROENTERITIS VIRAL 6 0.0003
904 LEUKOCYTOSIS 6 0.0003
905 VIRAL INFECTION 11 0.0003
906 DEPRESSION 75 0.0003
907 NEURALGIA 8 0.0003
908 BURNING SENSATION 23 0.0003
909 PRURITUS 125 0.0003
910 OSTEONECROSIS OF JAW 8 0.0003
911 THROMBOSIS 26 0.0003
912 HAEMOPTYSIS 9 0.0003
913 DYSKINESIA 13 0.0003
914 FOOT FRACTURE 6 0.0003
915 ADVERSE EVENT 29 0.0003
916 PULMONARY FIBROSIS 6 0.0003
917 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
918 JOINT STIFFNESS 8 0.0003
919 ABNORMAL BEHAVIOUR 12 0.0003
920 CARDIAC DISORDER 28 0.0003
921 TYPE 2 DIABETES MELLITUS 10 0.0003
922 DRUG WITHDRAWAL SYNDROME 26 0.0003
923 THROAT TIGHTNESS 8 0.0003
924 FLUSHING 30 0.0003
925 MIGRAINE 28 0.0003
926 NO ADVERSE EVENT 53 0.0003
927 BONE DENSITY DECREASED 9 0.0003
928 DEMENTIA 8 0.0003
929 ABASIA 7 0.0003
930 MOOD SWINGS 9 0.0003
931 DEATH 242 0.0003
932 DISTURBANCE IN ATTENTION 15 0.0003
933 AMNESIA 18 0.0003
934 SINUSITIS 28 0.0003
935 STAPHYLOCOCCAL INFECTION 9 0.0003
936 RENAL INJURY 8 0.0003
937 RESPIRATORY DISORDER 8 0.0003
938 DIABETES MELLITUS 20 0.0003
939 AGGRESSION 13 0.0003
940 COGNITIVE DISORDER 12 0.0003
941 SURGERY 15 0.0003
942 NEOPLASM MALIGNANT 17 0.0003
943 COMPLETED SUICIDE 21 0.0003
944 MEDICATION ERROR 14 0.0003
945 ABORTION SPONTANEOUS 10 0.0002
946 HIP FRACTURE 8 0.0002
947 ANGIOEDEMA 11 0.0002
948 MUSCULOSKELETAL PAIN 13 0.0002
949 INTENTIONAL DOSE OMISSION 7 0.0002
950 EYE SWELLING 9 0.0002
951 TINNITUS 11 0.0002
952 GAIT INABILITY 8 0.0002
953 EYE PRURITUS 8 0.0002
954 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
955 CARDIAC FAILURE CONGESTIVE 19 0.0002
956 FEMUR FRACTURE 7 0.0002
957 THERAPY INTERRUPTED 16 0.0002
958 EXTRA DOSE ADMINISTERED 9 0.0002
959 HAEMORRHAGE 23 0.0002
960 ACNE 16 0.0002
961 OCULAR HYPERAEMIA 10 0.0002
962 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
963 EMOTIONAL DISTRESS 24 0.0002
964 SKIN IRRITATION 9 0.0002
965 BLOOD GLUCOSE INCREASED 37 0.0002
966 EXPOSURE DURING PREGNANCY 12 0.0002
967 FUNGAL INFECTION 6 0.0002
968 CONVULSION 10 0.0002
969 DRUG DEPENDENCE 28 0.0002
970 CRYING 6 0.0002
971 PSORIASIS 21 0.0002
972 EYE PAIN 9 0.0002
973 UNEVALUABLE EVENT 12 0.0002
974 SUICIDAL IDEATION 14 0.0002
975 PRODUCT STORAGE ERROR 13 0.0001
976 MULTIPLE SCLEROSIS 7 0.0001
977 BLOOD GLUCOSE DECREASED 7 0.0001
978 THERAPEUTIC RESPONSE DECREASED 8 0.0001
979 DEPENDENCE 7 0.0001
980 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
981 DISEASE RECURRENCE 6 0.0001
982 INJECTION SITE PAIN 37 0.0001
983 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
984 INJECTION SITE BRUISING 9 0.0001
985 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
986 PROSTATE CANCER 9 0.0001
987 DEVICE ISSUE 10 0.0001
988 INJECTION SITE PRURITUS 7 0.0001
989 INJECTION SITE SWELLING 8 0.0001
990 EYE IRRITATION 6 0.0001
991 PRODUCT SUBSTITUTION ISSUE 6 0.0001
992 INJECTION SITE REACTION 7 0.0001
993 INJECTION SITE ERYTHEMA 12 0.0001
994 BREAST CANCER 8 0.0001